Response to letter by Grohskopf et al. in response to commentary by Small and Cronin

Affiliations

¹ University of California San Diego, United States.
² CDC's 2012 Childhood Immunization Champion; University of Florida College of Medicine, United States; UF Emerging Pathogens Institute, United States. Electronic address: Smallgroup2@aol.com.

Comment

Brendan J Cronin et al. Vaccine. 2017.

. 2017 Sep 18;35(39):5226.

doi: 10.1016/j.vaccine.2017.07.114.

¹ University of California San Diego, United States.
² CDC's 2012 Childhood Immunization Champion; University of Florida College of Medicine, United States; UF Emerging Pathogens Institute, United States. Electronic address: Smallgroup2@aol.com.

No abstract available

Comment on

Prevention and Control of Seasonal Influenza with Vaccines.
Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, Bresee JS. Grohskopf LA, et al. MMWR Recomm Rep. 2016 Aug 26;65(5):1-54. doi: 10.15585/mmwr.rr6505a1. MMWR Recomm Rep. 2016. PMID: 27560619
The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.
Small PA Jr, Cronin BJ. Small PA Jr, et al. Vaccine. 2017 Feb 22;35(8):1110-1112. doi: 10.1016/j.vaccine.2017.01.022. Epub 2017 Jan 22. Vaccine. 2017. PMID: 28118937 No abstract available.
Letter in response to commentary by Small and Cronin.
Grohskopf L, Foppa I, Flannery B, Fry A. Grohskopf L, et al. Vaccine. 2017 Sep 18;35(39):5225. doi: 10.1016/j.vaccine.2017.07.112. Vaccine. 2017. PMID: 28867044 Free PMC article. No abstract available.